Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy Subjects
Clinical trial NCT04019574 · COMPLETED
Trial details
- NCT number
- NCT04019574
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-20
- Primary completion
- 2019-10-22
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.